Biomerica (BMRA) EPS (Weighted Average and Diluted) (2011 - 2026)
Biomerica recorded quarterly EPS (Weighted Average and Diluted) of -$0.44 in Q1 2026, up 2.22% quarter-over-quarter from -$0.45 in Q4 2025, and up 8.33% year-over-year from -$0.41 in Q1 2025.
Biomerica's EPS (Weighted Average and Diluted) history runs 16 years deep, the most recent figure standing at -$0.44 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 8.33% year-over-year to -$0.44; the TTM figure through Feb 2026 stood at -$1.58 (up 57.75% YoY), while the FY2025 annual figure was -$2.16, up 23.94% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.44 for Q1 2026 at Biomerica, up from -$0.45 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q3 2025 to a low of -$2.57 in Q2 2024.
- A 5-year average of -$0.37 and a median of -$0.12 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) slumped 2470.0% in 2024 and soared 100.12% in 2025, its largest moves.
- Biomerica's EPS (Weighted Average and Diluted) stood at -$0.12 in 2022, then advanced by 25.0% to -$0.09 in 2023, then soared by 33.33% to -$0.06 in 2024, then sank by 650.0% to -$0.45 in 2025, then gained by 2.22% to -$0.44 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.44, -$0.45, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | -0.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.44 |
| Nov 30, 2025 | -0.45 |
| Aug 31, 2025 | 0.00 |
| May 31, 2025 | -0.69 |
| Feb 28, 2025 | -0.48 |
| Nov 30, 2024 | -0.06 |
| Aug 31, 2024 | -0.63 |
| May 31, 2024 | -2.57 |
| Feb 29, 2024 | -0.11 |
| Nov 30, 2023 | -0.09 |
| Aug 31, 2023 | -0.07 |
| May 31, 2023 | -0.10 |
| Feb 28, 2023 | -0.12 |
| Nov 30, 2022 | -0.12 |
| Aug 31, 2022 | -0.16 |
| May 31, 2022 | -0.14 |
| Feb 28, 2022 | -0.01 |
| Nov 30, 2021 | -0.09 |
| Aug 31, 2021 | -0.12 |
| May 31, 2021 | -0.13 |
| Feb 28, 2021 | -0.18 |
| Nov 30, 2020 | -0.15 |
| Aug 31, 2020 | -0.16 |
| May 31, 2020 | -0.07 |
| Feb 29, 2020 | -0.09 |
| Nov 30, 2019 | -0.05 |
| Aug 31, 2019 | -0.05 |
| May 31, 2019 | -0.08 |
| Feb 28, 2019 | -0.07 |
| Nov 30, 2018 | -0.05 |
| Aug 31, 2018 | -0.05 |
| May 31, 2018 | -0.08 |
| Feb 28, 2018 | -0.04 |
| Nov 30, 2017 | -0.03 |
| Aug 31, 2017 | -0.02 |
| May 31, 2017 | -0.04 |
| Feb 28, 2017 | -0.04 |
| Nov 30, 2016 | -0.02 |
| Aug 31, 2016 | -0.01 |
| May 31, 2016 | -0.16 |
| Feb 29, 2016 | -0.02 |
| Nov 30, 2015 | -0.01 |
| Aug 31, 2015 | -0.01 |
| May 31, 2015 | 0.04 |
| Feb 28, 2015 | -0.02 |
| Nov 30, 2014 | -0.03 |
| Aug 31, 2014 | -0.03 |
| May 31, 2014 | 0.02 |
| Nov 30, 2013 | -0.03 |
| Aug 31, 2013 | -0.02 |
| May 31, 2013 | 0.01 |
| Feb 28, 2013 | -0.01 |
| Nov 30, 2012 | 0.03 |
| Aug 31, 2012 | 0.04 |
| May 31, 2012 | 0.01 |
| Feb 29, 2012 | 0.03 |
| Nov 30, 2011 | 0.03 |
| Aug 31, 2011 | 0.02 |
| May 31, 2011 | 0.01 |
| Feb 28, 2011 | 0.01 |